Aura Biosciences, Inc.
AURA
$6.55
$0.081.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.69% | -6.38% | -22.77% | -3.47% | -3.20% |
| Total Depreciation and Amortization | -1.72% | 0.00% | -7.03% | 0.00% | 2.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.17% | 34.78% | 21.90% | -4.28% | 23.99% |
| Change in Net Operating Assets | 379.20% | 144.90% | -127.89% | 95.83% | 125.36% |
| Cash from Operations | 11.05% | 2.49% | -56.83% | 5.30% | 34.04% |
| Capital Expenditure | 79.14% | 37.46% | 12.32% | 35.05% | -496.59% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -33.28% | 0.02% | 193.20% | -49.77% | 114.74% |
| Cash from Investing | -32.99% | 0.40% | 200.28% | -50.16% | 111.16% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 48,357.29% | -82.32% | -24.16% | 762.65% | -67.19% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 72,742.71% | -82.32% | -24.16% | 762.65% | -67.19% |
| Foreign Exchange rate Adjustments | 142.86% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 958.33% | 3.93% | 234.66% | -222.97% | 125.64% |